Capricor Therapeutics, Inc. (CAPR) Social Stream



Capricor Therapeutics, Inc. (CAPR): $4.51

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CAPR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 396

in industry

Capricor Therapeutics Inc (CAPR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CAPR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 2 $14 $12 $13 $3.45 276.81%
2022-01-31 2 $18 $12 $15 $3.45 334.78%

The Trend in the Analyst Price Target


Over the past 12 months, CAPR's average price target has gone up $3.

CAPR reports an average of 184.36% for its upside potential over the past 34 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-05 0 12 9 10.5 3.86 172.02%
2021-06-21 0 12 9 10.5 5.41 94.09%
2021-08-24 0 12 9 10.5 4.12 154.85%
2021-11-10 2 14 12 13.0 3.51 270.37%
2022-01-31 2 18 12 15.0 3.57 320.17%

CAPR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CAPR as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, Capricor Therapeutics Inc's number of analysts covering the stock is greater than 9.38% of them.
  • In the context of all US stocks, Capricor Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 185.25% of them.
  • In the context of all US stocks, Capricor Therapeutics Inc's average analyst price target is higher than 28.8% of them.
  • In terms of how Capricor Therapeutics Inc fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 55.3% of that group.

Stocks similar to Capricor Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BPTS, BNOX, and BLRX.

Is CAPR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4927 seconds.